< Back to previous page

Project

Hyperspectral retinal imaging as a novel diagnostic biomarker for Alzheimer's disease.

Hyperspectral retinal imaging (HSRI) is a noval approach that could permit large-scale, inexpensive screening of populations at risk, thereby removing on of the principal bottlenecks to therapeutic advances in Alzheimer's disease. We will collect evidence of thHSRI that will be essential for its rational clinical use as an Alzheimer's disease imaging biomarker.

Date:1 Jan 2022 →  Today
Keywords:hyperspectral retinal imaging, Alzheimer's disease, HRSI
Disciplines:Physiology, Neurological and neuromuscular diseases